"","_1","Drug_name","Brand_name_3","DrugId","Brand_name_5","Sponsor","Properties","Indication","Indication_EFO","DiseaseId","TA","Year","id"
"1",1,"GLUCARPIDASE","Voraxaze",NA,NA,NA,"Recombinant bacterial enzyme that hydrolyses methotrexate","Toxic plasma methotrexate concentrations in patients with delayed methotrexate clearance",NA,NA,NA,2012,"CHEMBL1863515"
"2",2,"INGENOL MEBUTATE","Picato",NA,NA,NA,"MOA unknown","Actinic keratosis","EFO_0002496","actinic keratosis",NA,2012,"CHEMBL1863513"
"3",3,"AXITINIB","Inlyta",NA,NA,NA,"VEGFR1, -2 and -3 inhibitor","Advanced renal cell carcinoma",NA,NA,NA,2012,"CHEMBL1289926"
"4",4,"VISMODEGIB","Erivedge",NA,NA,NA,"Smoothened (Hedgehog pathway) inhibitor","Metastatic or locally advanced basal cell carcinoma",NA,NA,NA,2012,"CHEMBL473417"
"5",5,"IVACAFTOR","Kalydeco",NA,NA,NA,"CFTR potentiator","Cystic fibrosis in patients with the G551D mutation in the CFTR gene",NA,NA,NA,2012,"CHEMBL2010601"
"6",6,"TAFLUPROST","Zioptan",NA,NA,NA,"Selective prostaglandin F prostanoid receptor agonist","Elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension",NA,NA,NA,2012,"CHEMBL1963683"
"7",7,"LUCINACTANT","Surfaxin",NA,NA,NA,"Pulmonary surfactant","Prevention of respiratory distress syndrome",NA,NA,NA,2012,"CHEMBL1963685"
"8",8,"PEGINESATIDE ACETATE","Omontys",NA,NA,NA,"Synthetic, pegylated erythropoiesis-stimulating agent","Anaemia due to chronic kidney disease",NA,NA,NA,2012,"CHEMBL1963684"
"9",9,"FLORBETAPIR F-18","Amyvid",NA,NA,NA,"Radioactive diagnostic agent","Diagnostic agent to estimate amyloid-β plaques in patients with suspected Alzheimer's disease",NA,NA,NA,2012,NA
"10",10,"AVANAFIL","Stendra",NA,NA,NA,"PDE5 inhibitor","Erectile dysfunction","EFO_0004234","erectile dysfunction",NA,2012,"CHEMBL1963681"
"11",11,"TALIGLUCERASE ALFA","Elelyso",NA,NA,NA,"Recombinant β-glucocerebrosidase; produced in carrot cells","Gaucher's disease","MONDO_0018150","gaucher disease",NA,2012,"CHEMBL1964120"
"12",12,"PERTUZUMAB","Perjeta",NA,NA,NA,"HER2-targeting mAb","HER2-positive metastatic breast cancer",NA,NA,NA,2012,"CHEMBL2007641"
"13",13,"LORCASERIN","Belviq",NA,NA,NA,"5-HT2C receptor agonist","Obesity","EFO_0001073","obesity",NA,2012,"CHEMBL360328"
"14",14,"MIRABEGRON","Myrbetriq",NA,NA,NA,"β3-adrenergic receptor agonist","Overactive bladder","EFO_1000781","overactive bladder",NA,2012,"CHEMBL2095212"
"15",15,"CITRIC ACID","Prepopik",NA,NA,NA,"Osmotic and stimulant laxatives","Cleansing of the colon before colonoscopy",NA,NA,NA,2012,"CHEMBL1261"
"16",15,"MAGNESIUM OXIDE","Prepopik",NA,NA,NA,"Osmotic and stimulant laxatives","Cleansing of the colon before colonoscopy",NA,NA,NA,2012,"CHEMBL1200572"
"17",15,"SODIUM PICOSULFATE","Prepopik",NA,NA,NA,"Osmotic and stimulant laxatives","Cleansing of the colon before colonoscopy",NA,NA,NA,2012,"CHEMBL1697768"
"18",16,"CARFILZOMIB","Kyprolis",NA,NA,NA,"20S proteasome inhibitor","Multiple myeloma","EFO_0001378","multiple myeloma",NA,2012,"CHEMBL451887"
"19",17,"ACLIDINIUM BROMIDE","Tudorza Pressair",NA,NA,NA,"Long-acting antimuscarinic agent","Bronchospasms associated with COPD",NA,NA,NA,2012,"CHEMBL551466"
"20",18,"ZIV-AFLIBERCEPT","Zaltrap",NA,NA,NA,"Recombinant fusion protein that binds VEGFA, VEGFB and PIGF","Metastatic colorectal cancer","EFO_1001480","metastatic colorectal cancer",NA,2012,NA
"21",19,"COBICISTAT","Stribild",NA,NA,NA,"Cytochrome P450 inhibitor; HIV-1 integrase inhibitor; NRTI; acyclic nucleoside phosphonate analogue","HIV-1 infection","EFO_0000180","hiv-1 infection",NA,2012,"CHEMBL2095208"
"22",19,"ELVITEGRAVIR","Stribild",NA,NA,NA,"Cytochrome P450 inhibitor; HIV-1 integrase inhibitor; NRTI; acyclic nucleoside phosphonate analogue","HIV-1 infection","EFO_0000180","hiv-1 infection",NA,2012,"CHEMBL204656"
"23",19,"EMTRICITABINE","Stribild",NA,NA,NA,"Cytochrome P450 inhibitor; HIV-1 integrase inhibitor; NRTI; acyclic nucleoside phosphonate analogue","HIV-1 infection","EFO_0000180","hiv-1 infection",NA,2012,"CHEMBL885"
"24",19,"TENOFOVIR DISOPROXIL FUMARATE","Stribild",NA,NA,NA,"Cytochrome P450 inhibitor; HIV-1 integrase inhibitor; NRTI; acyclic nucleoside phosphonate analogue","HIV-1 infection","EFO_0000180","hiv-1 infection",NA,2012,"CHEMBL1486"
"25",20,"TBO-FILGRASTIM","Neutroval",NA,NA,NA,"Methionyl human G-CSF","Severe neutropaenia in patients with non-myeloid malignancies",NA,NA,NA,2012,NA
"26",21,"LINACLOTIDE","Linzess",NA,NA,NA,"Guanylyl cyclase C agonist","Irritable bowel syndrome with constipation; chronic idiopathic constipation",NA,NA,NA,2012,"CHEMBL3301675"
"27",22,"ENZALUTAMIDE","Xtandi",NA,NA,NA,"Androgen receptor inhibitor","Metastatic castration-resistant prostate cancer",NA,NA,NA,2012,"CHEMBL1082407"
"28",23,"BOSUTINIB MONOHYDRATE","Bosulif",NA,NA,NA,"BCR–ABL inhibitor; SRC family kinase inhibitor","Chronic, accelerated or blast phase Ph+ chronic myelogenous leukaemia",NA,NA,NA,2012,NA
"29",24,"TERIFLUNOMIDE","Aubagio",NA,NA,NA,"Dihydroorotate dehydrogenase inhibitor","Relapsing forms of multiple sclerosis",NA,NA,NA,2012,"CHEMBL973"
"30",25,"CHOLINE C-11",NA,NA,NA,NA,"Radiolabelled choline analogue","Diagnostic agent for imaging of patients with suspected prostate cancer recurrence",NA,NA,NA,2012,"CHEMBL2095207"
"31",26,"REGORAFENIB","Stivarga",NA,NA,NA,"Multikinase inhibitor with targets including RET, VEGFR1, -2, -3 and KIT","Metastatic colorectal cancer","EFO_1001480","metastatic colorectal cancer",NA,2012,"CHEMBL1946170"
"32",27,"OCRIPLASMIN","Jetrea",NA,NA,NA,"Recombinant truncated form of human plasmin","Symptomatic vitreomacular adhesion",NA,NA,NA,2012,"CHEMBL2095222"
"33",28,"PERAMPANEL","Fycompa",NA,NA,NA,"Non-competitive ionotropic AMPA glutamate receptor antagonist","Partial-onset seizures in patients with epilepsy",NA,NA,NA,2012,"CHEMBL1214124"
"34",29,"OMACETAXINE MEPESUCCINATE","Synribo",NA,NA,NA,"MOA unknown","Chronic or accelerated-phase chronic myeloid leukaemia",NA,NA,NA,2012,"CHEMBL46286"
"35",30,"TOFACITINIB","Xeljanz",NA,NA,NA,"JAK inhibitor","Severely active rheumatoid arthritis",NA,NA,NA,2012,"CHEMBL221959"
"36",31,"CABOZANTINIB","Cometriq",NA,NA,NA,"Multikinase inhibitor with targets including RET, MET, VEGFR1, -2, -3, KIT and FLT3","Progressive, metastatic medullary thyroid cancer",NA,NA,NA,2012,"CHEMBL2105717"
"37",32,"PONATINIB","Iclusig",NA,NA,NA,"Multikinase inhibitor with targets including Bcr–Abl, KIT, RET and FLT3","Chronic, accelerated or blast-phase chronic myeloid leukaemia",NA,NA,NA,2012,"CHEMBL1171837"
"38",33,"PASIREOTIDE DIASPARTATE","Signifor",NA,NA,NA,"Somatostatin analogue","Cushing's disease",NA,NA,NA,2012,"CHEMBL3039588"
"39",34,"RAXIBACUMAB",NA,NA,NA,NA,"Human mAb against Bacillus anthracis toxin","Anthrax","EFO_0000778","anthrax infection",NA,2012,"CHEMBL2108638"
"40",35,"TEDUGLUTIDE","Gattex",NA,NA,NA,"GLP2 analogue","Short bowel syndrome","MONDO_0015183","short bowel syndrome",NA,2012,"CHEMBL2104987"
"41",36,"LOMITAPIDE","Juxtapid",NA,NA,NA,"Microsomal triglyceride transfer protein inhibitor","Homozygous familial hypercholesterolaemia",NA,NA,NA,2012,"CHEMBL354541"
"42",37,"APIXABAN","Eliquis",NA,NA,NA,"Factor Xa inhibitor","Stroke and systemic embolism in patients with non-valvular atrial fibrillation",NA,NA,NA,2012,"CHEMBL231779"
"43",38,"BEDAQUILINE","Sirturo",NA,NA,NA,"Diarylquinoline antimycobacterial","Pulmonary multidrug-resistant tuberculosis",NA,NA,NA,2012,"CHEMBL376488"
"44",39,"CROFELEMER","Fulyzaq",NA,NA,NA,"CFTR and CaCC channel inhibitors","HIV-associated diarrhoea",NA,NA,NA,2012,"CHEMBL2108184"
